Lulioas Cream contains Luliconazole 1% w/w, a topical antifungal agent belonging to the imidazole class, indicated for the treatment of superficial fungal infections of the skin. Luliconazole exhibits broad-spectrum antifungal activity against dermatophytes, yeasts, and molds by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Lulioas Cream is primarily prescribed for conditions such as tinea corporis, tinea cruris, and tinea pedis, providing effective relief from symptoms including itching, redness, and scaling. The cream formulation ensures optimal skin penetration and localized action with minimal systemic absorption, reducing the risk of systemic side effects. It is recommended to apply a thin layer of Lulioas Cream to the affected area once daily, preferably for a duration of 2 to 4 weeks depending on the severity and type of infection. Patients should be advised to maintain good hygiene and avoid occlusive dressings unless directed by a healthcare professional. Lulioas Cream is generally well tolerated; however, mild local reactions such as burning sensation, irritation, or erythema may occur. Use with caution in patients with known hypersensitivity to luliconazole or any cream excipients.